Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Cell Mol Med. 2011 Oct;15(10):2117–2129. doi: 10.1111/j.1582-4934.2010.01241.x

Figure 2. Intramyocardial injection of MPCs post-MI attenuates LV dysfunction and remodeling.

Figure 2

Echocardiography was performed to assess fractional shortening (A) and LV diastolic areas (LVAD) (B). Myocardial sections were stained to count TUNEL+ apoptotic myocytes (C). Masson’s Trichrome-stained sections were examined for myocardial fibrosis (D). vWF+ vessels per high power field (HPF) were quantified (E). For figures A–E, data is represented as mean±sem. N=10–12/group. *P<0.05.